Australian Clinical Labs (ASX:ACL) said Greg Horan was appointed Group Chief Executive Officer and executive director, to succeed Melinda McGrath, according to a Thursday Australian bourse filing.
Horan will join Australian Clinical Labs on June 1 as Group CEO-elect, and his term as Group CEO will take effect from Aug. 31.
Horan was most recently CEO of Healthscope.
SHAPE Australia (ASX:SHA) agreed to acquire Australian Professional Shopfitters from Handa Manufacturing for up to AU$29.4 million, according to a Thursday filing with the Australian bourse.The transaction includes an upfront consideration of AU$20.4 million and up to AU$9 million in contingent consideration over a two-year earn-out period, the filing said.Consideration and transaction costs for the acquisition will be funded through cash and scrip, per the filing.
Stride Property (NZE:SPG) reported Thursday fiscal 2026 adjusted funds from operations of NZ$0.0754 per share, up from NZ$0.0748 a year earlier.Analysts polled by FactSet expected NZ$0.07.Revenue for the 12 months ended March 31 was NZ$81.8 million, down around 8.5% from a year earlier. Analysts surveyed by FactSet expected NZ$91 million.The board declared a combined fiscal 2026 dividend of NZ$0.08 per share, unchanged from a year earlier. It also issued a combined cash dividend guidance of NZ$0.08 for fiscal 2027.The company's shares were down 1% in recent Thursday trade.
IPH (ASX:IPH) appointed Anthony O'Malley as its new managing director and Chief Executive Officer with effect from July 1, succeeding Andrew Blattman, who plans to retire, according to a Thursday Australian bourse filing.O'Malley was most recently the global legal business solutions leader at PwC. Blattman will continue to provide support to the firm until Nov. 30.